Merlin Young - gentle and effective acupuncture for everyone


Since 2007 my friend and colleague Jenny Craig and I have been involved in a systematic investigation of the possibility that small-con direct moxa (as used in Japan in the decades before the arrival of TB drugs) might possibly help combat the deadly and growing scourge of TB in the developing world. To this end in 2008 we co-founded "Moxafrica" a charity with the aim of appropriately investigating this. 

(Moxafrica - UK Charity Commission Registration Number: 1128408)

We began work in Uganda in 2009, and then initiated follow-up pilot studies in South Africa the following year.

Moxafrica is now funding and collaborating in a Phase II Randimised Control Trial (RCT) in Uganda with Makerere University's School of Health Sciences. It is potentially one of the most exciting ventures of research in medicine today - of potential benefit to literally millions of people who are at desperate risk of drug-resistant disease. The research is in the hands of scientists - and we eagerly await their final judgements.

You can find a lot of information in the Moxafrica website - not only about Moxafrica, but also about TB today particularly in Africa - the full extent of which is rarely (if ever) properly discussed in the media.

If you want to generally learn about Moxafrica, we suggest you look at one of the videos, consider the original evidence base, the patient feedback, the programme, the budget, and/or the FAQTS.

If you want to know about the exciting and vital live Scientific Research on the effects of moxa on TB patients then click on the research page, but you can also find information on the pilot studies in the Uganda and South Africa sections.

If you want to get some idea of the truly colossal and intractable scale of the problem of TB in the developing world, please click on the Whole Picture or "what the experts are saying".

If you want to get an idea of how the project has developed from its outset, you can get this from the News page.

It is really impossible to grasp the potential of this project without understanding the existing complexities of treating this disease in Africa alongside HIV/AIDS, particularly as the rate of drug resistant disease rises. This is an African health problem, but is nevertheless one of the most pressing humanitarian problems of our age.

Most importantly of all, if you want help this potentially immensely important project to progress, click on DONATE!